nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—cornea—ocular cancer	0.0609	0.213	CbGeAlD
Minocycline—CYCS—pineal body—ocular cancer	0.0434	0.152	CbGeAlD
Minocycline—SLC22A8—optic choroid—ocular cancer	0.0199	0.0697	CbGeAlD
Minocycline—CYCS—eye—ocular cancer	0.0132	0.046	CbGeAlD
Minocycline—CYCS—retina—ocular cancer	0.013	0.0456	CbGeAlD
Minocycline—CASP1—epithelium—ocular cancer	0.0125	0.0437	CbGeAlD
Minocycline—CYCS—epithelium—ocular cancer	0.012	0.0421	CbGeAlD
Minocycline—CASP3—eye—ocular cancer	0.0113	0.0394	CbGeAlD
Minocycline—CASP3—retina—ocular cancer	0.0112	0.0391	CbGeAlD
Minocycline—CASP3—epithelium—ocular cancer	0.0103	0.0361	CbGeAlD
Minocycline—CASP1—lymphoid tissue—ocular cancer	0.00964	0.0337	CbGeAlD
Minocycline—CYCS—lymphoid tissue—ocular cancer	0.00928	0.0324	CbGeAlD
Minocycline—IL1B—eye—ocular cancer	0.00901	0.0315	CbGeAlD
Minocycline—IL1B—epithelium—ocular cancer	0.00824	0.0288	CbGeAlD
Minocycline—CASP3—lymphoid tissue—ocular cancer	0.00794	0.0278	CbGeAlD
Minocycline—MMP9—eye—ocular cancer	0.00751	0.0262	CbGeAlD
Minocycline—MMP9—epithelium—ocular cancer	0.00687	0.024	CbGeAlD
Minocycline—IL1B—lymphoid tissue—ocular cancer	0.00635	0.0222	CbGeAlD
Minocycline—MMP9—lymphoid tissue—ocular cancer	0.00529	0.0185	CbGeAlD
Minocycline—ALOX5—lymphoid tissue—ocular cancer	0.00418	0.0146	CbGeAlD
Minocycline—SLC22A8—eye—ocular cancer	0.00401	0.014	CbGeAlD
Minocycline—VEGFA—Endochondral Ossification—TGFB1—ocular cancer	0.000634	0.000887	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000629	0.000881	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000627	0.000879	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.000619	0.000867	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.000618	0.000866	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.000617	0.000864	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.000612	0.000857	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000609	0.000853	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—MDM2—ocular cancer	0.000602	0.000843	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000593	0.000831	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—ocular cancer	0.000588	0.000824	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CDKN1B—ocular cancer	0.000586	0.000821	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MYC—ocular cancer	0.000585	0.000819	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—ocular cancer	0.000583	0.000817	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—AKT1—ocular cancer	0.000583	0.000816	CbGpPWpGaD
Minocycline—MMP9—FGF signaling pathway—AKT1—ocular cancer	0.000581	0.000814	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—ocular cancer	0.000579	0.000811	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—HRAS—ocular cancer	0.000575	0.000805	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000574	0.000804	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—HRAS—ocular cancer	0.00057	0.000799	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—ocular cancer	0.000559	0.000783	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCND1—ocular cancer	0.000559	0.000783	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—MDM2—ocular cancer	0.000557	0.00078	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CCND3—ocular cancer	0.000556	0.000779	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN1B—ocular cancer	0.000549	0.00077	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000548	0.000767	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000547	0.000766	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000547	0.000766	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000541	0.000758	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—HRAS—ocular cancer	0.00054	0.000756	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000537	0.000752	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.000537	0.000752	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—ocular cancer	0.000535	0.00075	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TP53—ocular cancer	0.000531	0.000743	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00053	0.000743	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00053	0.000742	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—ocular cancer	0.00053	0.000742	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—ocular cancer	0.000529	0.00074	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN2B—ocular cancer	0.000528	0.000739	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.000527	0.000738	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—ocular cancer	0.000515	0.000722	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000511	0.000716	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.000508	0.000712	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.000508	0.000711	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—AKT1—ocular cancer	0.000507	0.000711	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—AKT1—ocular cancer	0.000507	0.000711	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CDKN1A—ocular cancer	0.000507	0.00071	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000505	0.000707	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000504	0.000706	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.000504	0.000706	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—AKT1—ocular cancer	0.000504	0.000705	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—AKT1—ocular cancer	0.000495	0.000693	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SAG—ocular cancer	0.000494	0.000692	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—HRAS—ocular cancer	0.000493	0.000691	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HRAS—ocular cancer	0.000493	0.00069	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—AKT1—ocular cancer	0.000489	0.000685	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—MYC—ocular cancer	0.000487	0.000682	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000486	0.00068	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—E2F1—ocular cancer	0.000484	0.000678	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—EP300—ocular cancer	0.000482	0.000676	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—ocular cancer	0.00048	0.000673	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.000469	0.000657	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000457	0.000641	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000456	0.000638	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—MDM2—ocular cancer	0.000455	0.000638	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MYC—ocular cancer	0.000448	0.000628	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—ocular cancer	0.000447	0.000627	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—AKT1—ocular cancer	0.000446	0.000625	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—AKT1—ocular cancer	0.000446	0.000625	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MYC—ocular cancer	0.000441	0.000617	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—AKT1—ocular cancer	0.00044	0.000617	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00044	0.000616	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000439	0.000616	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000438	0.000614	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—E2F5—ocular cancer	0.000437	0.000613	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000436	0.00061	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.000435	0.000609	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—ocular cancer	0.000433	0.000606	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00043	0.000602	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—E2F4—ocular cancer	0.000428	0.0006	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—ocular cancer	0.000427	0.000597	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—ocular cancer	0.000423	0.000592	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RBL1—ocular cancer	0.00042	0.000589	CbGpPWpGaD
Minocycline—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ocular cancer	0.00042	0.000588	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDK2—ocular cancer	0.000418	0.000585	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNA11—ocular cancer	0.000417	0.000584	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CDKN1B—ocular cancer	0.000416	0.000582	CbGpPWpGaD
Minocycline—MMP9—CXCR4-mediated signaling events—AKT1—ocular cancer	0.000408	0.000572	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—ocular cancer	0.0004	0.00056	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000398	0.000558	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDK4—ocular cancer	0.000395	0.000553	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GNAQ—ocular cancer	0.000388	0.000543	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—CDKN1A—ocular cancer	0.000384	0.000538	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—AKT1—ocular cancer	0.000382	0.000535	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000379	0.000531	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—MDM2—ocular cancer	0.000376	0.000527	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—ocular cancer	0.000368	0.000516	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000368	0.000516	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000368	0.000515	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000367	0.000514	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—ocular cancer	0.000367	0.000514	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—E2F3—ocular cancer	0.000364	0.00051	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—ocular cancer	0.000362	0.000507	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000361	0.000506	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—AKT1—ocular cancer	0.00036	0.000505	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000357	0.000501	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000356	0.000498	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HDAC1—ocular cancer	0.00035	0.00049	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNA11—ocular cancer	0.000348	0.000487	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000346	0.000485	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—ocular cancer	0.000345	0.000484	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1B—ocular cancer	0.000343	0.000481	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—RB1—ocular cancer	0.000343	0.000481	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SAG—ocular cancer	0.000343	0.00048	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TFDP1—ocular cancer	0.000339	0.000474	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—ocular cancer	0.000338	0.000474	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—AKT1—ocular cancer	0.000338	0.000473	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—CCND1—ocular cancer	0.000332	0.000464	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.000331	0.000463	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00033	0.000462	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GNAQ—ocular cancer	0.000323	0.000453	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00032	0.000448	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000319	0.000447	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CDKN1A—ocular cancer	0.000317	0.000444	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—ocular cancer	0.000312	0.000437	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—AKT1—ocular cancer	0.000306	0.000428	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—ocular cancer	0.000305	0.000428	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000305	0.000427	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000304	0.000426	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—E2F5—ocular cancer	0.000304	0.000425	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—EP300—ocular cancer	0.000302	0.000422	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SAG—ocular cancer	0.000298	0.000417	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—E2F4—ocular cancer	0.000297	0.000417	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MDM2—ocular cancer	0.000293	0.00041	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.000292	0.000409	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RBL1—ocular cancer	0.000292	0.000409	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—AKT1—ocular cancer	0.000276	0.000386	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CDK4—ocular cancer	0.000275	0.000386	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—AKT1—ocular cancer	0.00027	0.000378	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAML2—ocular cancer	0.000269	0.000377	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1B—ocular cancer	0.000267	0.000374	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000265	0.000371	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000264	0.00037	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—E2F5—ocular cancer	0.000264	0.000369	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000262	0.000368	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—E2F4—ocular cancer	0.000258	0.000362	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RBL1—ocular cancer	0.000253	0.000355	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—E2F3—ocular cancer	0.000253	0.000354	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—ocular cancer	0.00025	0.00035	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CDK2—ocular cancer	0.000248	0.000348	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CDKN1A—ocular cancer	0.000247	0.000345	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CDK4—ocular cancer	0.000239	0.000335	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000235	0.000329	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TFDP1—ocular cancer	0.000235	0.000329	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—ocular cancer	0.000235	0.000329	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNA11—ocular cancer	0.000235	0.000329	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—EP300—ocular cancer	0.000235	0.000329	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.00023	0.000322	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000222	0.00031	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—ocular cancer	0.000221	0.000309	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—E2F3—ocular cancer	0.00022	0.000307	CbGpPWpGaD
Minocycline—CASP1—Immune System—MDM2—ocular cancer	0.000219	0.000307	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GNAQ—ocular cancer	0.000218	0.000306	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000218	0.000305	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNA11—ocular cancer	0.000214	0.0003	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—ocular cancer	0.000209	0.000293	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—ocular cancer	0.000206	0.000289	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TFDP1—ocular cancer	0.000204	0.000286	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1B—ocular cancer	0.0002	0.00028	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNAQ—ocular cancer	0.000199	0.000279	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HDAC1—ocular cancer	0.000197	0.000276	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAML2—ocular cancer	0.000187	0.000262	CbGpPWpGaD
Minocycline—CASP1—Immune System—CDKN1A—ocular cancer	0.000185	0.000259	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—ocular cancer	0.000184	0.000258	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000184	0.000257	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—ocular cancer	0.000182	0.000255	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN2B—ocular cancer	0.000176	0.000247	CbGpPWpGaD
Minocycline—CASP1—Immune System—EP300—ocular cancer	0.000176	0.000246	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—ocular cancer	0.000168	0.000235	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—EP300—ocular cancer	0.000164	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000163	0.000229	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNA11—ocular cancer	0.000163	0.000228	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAML2—ocular cancer	0.000162	0.000227	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—E2F1—ocular cancer	0.000162	0.000227	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000161	0.000225	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—ocular cancer	0.000157	0.00022	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAQ—ocular cancer	0.000151	0.000212	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—ocular cancer	0.000142	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—EP300—ocular cancer	0.000142	0.000199	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNA11—ocular cancer	0.000141	0.000198	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—EP300—ocular cancer	0.000139	0.000195	CbGpPWpGaD
Minocycline—IL1B—Immune System—MDM2—ocular cancer	0.000137	0.000192	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HDAC1—ocular cancer	0.000137	0.000191	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—ocular cancer	0.000136	0.000191	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAQ—ocular cancer	0.000132	0.000184	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1B—ocular cancer	0.000125	0.000175	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—ocular cancer	0.000124	0.000173	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN2B—ocular cancer	0.000122	0.000171	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—ocular cancer	0.000121	0.00017	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—ocular cancer	0.00012	0.000168	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HDAC1—ocular cancer	0.000119	0.000166	CbGpPWpGaD
Minocycline—CYCS—Metabolism—EP300—ocular cancer	0.000116	0.000163	CbGpPWpGaD
Minocycline—IL1B—Immune System—CDKN1A—ocular cancer	0.000115	0.000162	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—E2F1—ocular cancer	0.000112	0.000157	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—ocular cancer	0.000112	0.000157	CbGpPWpGaD
Minocycline—IL1B—Immune System—EP300—ocular cancer	0.00011	0.000154	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN2B—ocular cancer	0.000106	0.000149	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—ocular cancer	0.000106	0.000149	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—ocular cancer	9.98e-05	0.00014	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—ocular cancer	9.89e-05	0.000139	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MDM2—ocular cancer	9.78e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—E2F1—ocular cancer	9.75e-05	0.000137	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—ocular cancer	9.73e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—ocular cancer	9.54e-05	0.000134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1B—ocular cancer	8.93e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—ocular cancer	8.59e-05	0.00012	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCND1—ocular cancer	8.52e-05	0.000119	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—ocular cancer	8.42e-05	0.000118	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CDKN1A—ocular cancer	8.24e-05	0.000115	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—EP300—ocular cancer	7.84e-05	0.00011	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—ocular cancer	7.51e-05	0.000105	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—EP300—ocular cancer	7.16e-05	0.0001	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—ocular cancer	7.02e-05	9.84e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—ocular cancer	6.83e-05	9.57e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—ocular cancer	6.82e-05	9.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MDM2—ocular cancer	6.79e-05	9.51e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—ocular cancer	6.63e-05	9.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1B—ocular cancer	6.2e-05	8.68e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCND1—ocular cancer	5.91e-05	8.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MDM2—ocular cancer	5.89e-05	8.26e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CDKN1A—ocular cancer	5.72e-05	8.01e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—ocular cancer	5.61e-05	7.86e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—EP300—ocular cancer	5.44e-05	7.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1B—ocular cancer	5.38e-05	7.54e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—ocular cancer	5.37e-05	7.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCND1—ocular cancer	5.13e-05	7.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDKN1A—ocular cancer	4.97e-05	6.96e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—ocular cancer	4.74e-05	6.65e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—ocular cancer	4.74e-05	6.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—ocular cancer	4.73e-05	6.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—EP300—ocular cancer	4.73e-05	6.62e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—ocular cancer	4.33e-05	6.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—ocular cancer	4.12e-05	5.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—ocular cancer	4.11e-05	5.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—ocular cancer	3.9e-05	5.46e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—ocular cancer	3.73e-05	5.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—ocular cancer	3.38e-05	4.74e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—ocular cancer	3.29e-05	4.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—ocular cancer	3.23e-05	4.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—ocular cancer	2.86e-05	4e-05	CbGpPWpGaD
